Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles S Fuchs

Showing results (1-10 of 671) with videos related to

Pageof 68
Sort By:
Seminars in Oncology|September 26, 2003
Current and ongoing trials with irinotecan in the United StatesCharles S Fuchs
Clinical Advances in Hematology & Oncology : H&O|May 12, 2011
The role of aspirin in prevention and management of colorectal cancerCharles S Fuchs
Clinical Advances in Hematology & Oncology : H&O|June 14, 2014
Aspirin, the new targeted therapy in colorectal cancerCharles S Fuchs
JAMA Oncology|March 8, 2019
Omitted Disclosures of Potential Conflicts of Interest in Articles Published in JAMA OncologyCharles S Fuchs
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2018
Reply to L. Fornaro et alCharles S Fuchs, Donna Niedzwiecki
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2013
Aspirin therapy for colorectal cancer with PIK3CA mutation: simply complex!Charles S Fuchs, Shuji Ogino
Seminars in Radiation Oncology|April 30, 2002
Chemotherapy options for gastric cancerJeffrey A Meyerhardt, Charles S Fuchs
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 15, 2005
Obesity and pancreatic cancer: overall evidence and latency periodDominique S Michaud, Charles S Fuchs
Oncology (Williston Park, N.Y.)|June 13, 2003
Adjuvant therapy in gastric cancer: can we prevent recurrences?Jeffrey A Meyerhardt, Charles S Fuchs
Seminars in Oncology|October 3, 2003
The experience with oxaliplatin in the treatment of upper gastrointestinal carcinomasPaulo M Hoff, Charles S Fuchs
Pageof 68

Showing results (1-10 of 671) with videos related to

Sort By:
Pageof 68
Seminars in Oncology|September 26, 2003
Current and ongoing trials with irinotecan in the United StatesCharles S Fuchs
Clinical Advances in Hematology & Oncology : H&O|May 12, 2011
The role of aspirin in prevention and management of colorectal cancerCharles S Fuchs
Clinical Advances in Hematology & Oncology : H&O|June 14, 2014
Aspirin, the new targeted therapy in colorectal cancerCharles S Fuchs
JAMA Oncology|March 8, 2019
Omitted Disclosures of Potential Conflicts of Interest in Articles Published in JAMA OncologyCharles S Fuchs
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2018
Reply to L. Fornaro et alCharles S Fuchs, Donna Niedzwiecki
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2013
Aspirin therapy for colorectal cancer with PIK3CA mutation: simply complex!Charles S Fuchs, Shuji Ogino
Seminars in Radiation Oncology|April 30, 2002
Chemotherapy options for gastric cancerJeffrey A Meyerhardt, Charles S Fuchs
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 15, 2005
Obesity and pancreatic cancer: overall evidence and latency periodDominique S Michaud, Charles S Fuchs
Oncology (Williston Park, N.Y.)|June 13, 2003
Adjuvant therapy in gastric cancer: can we prevent recurrences?Jeffrey A Meyerhardt, Charles S Fuchs
Seminars in Oncology|October 3, 2003
The experience with oxaliplatin in the treatment of upper gastrointestinal carcinomasPaulo M Hoff, Charles S Fuchs
Pageof 68